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In many infectious diseases, the immune response operates as a double-edged sword.
While required for protective immunity, infection-induced inflammation can be detrimental
if it is not properly controlled, causing collateral body damage and potentially leading
to death. It is in this context that the potent anti-inflammatory cytokine interleukin-10
(IL-10) is required to dampen the pro-inflammatory immune response that hallmarks
trypanosomosis. Effective control of this infection requires not just the action of antibodies
specific for the parasite’s variable surface glycoprotein (VSG) coat antigens, but also a
pro-inflammatory immune response mediated mainly by IFNγ, TNF, and NO. However,
strict control of inflammation is mandatory, as IL-10-deficient mice succumb from an
unrestrained cytokine storm within 10 days of a Trypanosome brucei infection. The
relevant cellular source of IL-10 and the associated molecular mechanisms implicated
in its trypanosomosis associated production are poorly understood. Using an IL-10
reporter mouse strain (Vert-X), we demonstrate here that NK cells, CD8+ T cells and
CD4+ T cells as well as B cells and plasma cells constitute potential cellular sources
of IL-10 within the spleen and liver during acute infection. The IL-10 wave follows
peak pro-inflammatory cytokine production, which accompanied the control of peak
parasitemia. Similar results were observed following conventional experimental needle
infection and physiological infections via T. brucei-infected tsetse flies. Our results show
that conditional T cell-specific ablation of the IL-10 regulating Prdm1 gene (encoding
for the Blimp-1 transcription factor), leads to an uncontrolled trypanosome-induced
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pro-inflammatory syndrome like the one observed in infected IL-10-deficient mice. This
result indicates that the biological role of IL-10-derived from non-T cells, including NK
cells, is of minor importance when considering host survival. The cytokine IL-27 that
is also considered to be an IL-10 regulator, did not affect IL-10 production during
infection. Together, these data suggest that T. brucei activates a Blimp-1-dependent
IL-10 regulatory pathway in T cells that acts as a critical anti-inflammatory rheostat,
mandatory for host survival during the acute phase of parasitemia.
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INTRODUCTION
During inflammation, immune regulatory cytokines are
mandatory to preserve host integrity by controlling pathogen-
induced immune responses (1). IL-10 is a pleiotropic
anti-inflammatory cytokine that dampens many inflammatory
reactions (2). Hence, IL-10-deficient mice are prone to
uncontrolled inflammation-mediated immunopathologies, such
as spontaneous colitis potentially leading to tumorigenesis
and chronic inflammation-driven auto-immunity (3). During
infection, the genetic or pharmacological inhibition of IL-10
usually leads to a better control of infection, but this is often
associated with enhanced immuno-pathology and, in some
infectious models, death (4, 5). Macrophages and dendritic
cells constitute targets of the suppressive function of IL-10,
promoting their differentiation toward a suppressive and
tolerizing phenotype (6, 7). Recently, many cell types have been
shown to secrete IL-10 during infections, namely NK cells,
dendritic cells, Th1 cells, CD8+ T, regulatory T and B cells, and
even non-immune cells, such as hepatocytes and keratinocytes
(8–15). Different transcription factors and cytokines have been
implicated in the production of IL-10 depending on the cell type.
For example, Foxp3, Aryl hydrocarbon Receptor, Blimp1 and
IL-27 were shown to modulate IL-10 production by Tregs, NK,
and Th1 cells, respectively (12, 16–22). African trypanosomes
are extracellular protozoan hemoflagellated parasites transmitted
by the bite of infected tsetse flies (genus Glossina). These
parasites are endemic in Sub-Saharan Africa, causing African
trypanosomosis in human (also called sleeping sickness) and
Nagana disease in livestock. About 60 million people are at
risk and Nagana causes three million cattle deaths every year
due to weight loss and anemia. The associated economic loss
in livestock production is estimated at 4 billion USD per year
(23). Murine models are considered valuable tools to study
the interactions between parasites and hosts that contribute
to immunopathogenicity. Experimental T. brucei infections in
mice have shown that clearance of the first parasitemia peak
is dependent on an early strong type 1 inflammatory immune
response, involving IFNγ, Nitric Oxide (NO) and Tumor
Necrosis Factor (TNF) production, which correlates with an early
activation of monocytes, the recruitment of splenic neutrophils
and the development of anemia (24–28). Yet, the production of
IL-10 is essential to dampen this type 1 immune response after
parasitemia has been cleared to prevent the development of a
hyper-inflammation syndrome and death (6, 29, 30). Despite the
importance of IL-10 in T. brucei pathogenesis, the in vivo cellular
source of IL-10 and the associated molecular mechanism(s)
implicated in its production remain poorly understood. In
this study, we report that increasing levels of IL-10 are being
measured in both infected tissue and serum following clearance
of the first parasitemia peak. Using IL-10 reporter [Vert-X (31)]
mice, we show that NK cells, CD8+ T cells and CD4+ T cells
are important cellular sources of IL-10 within infected liver and
spleen tissues around day 6 post infection (p.i.), following the
peak of pro-inflammatory cytokine production. Post-parasitemia
peak (around day 8–9 p.i.), the cellular source of IL-10 is still
similar in the liver, whereas, surprisingly, the main splenic
IL-10-producing cells become plasma B cells. These results
were first obtained in a conventional experimental infection
model in which mice were challenged with T. brucei parasites via
intraperitoneal needle injection. Subsequently, all results were
confirmed following a natural infection via T. brucei-bearing
tsetse flies. Using T cell conditional Blimp-1 knockout mice,
we demonstrate the importance of this transcription factor in
dampening trypanosome-mediated inflammation, mainly via the




All experiments complied with the ECPVA guidelines (CETS
n◦ 123) and were approved by the VUB Ethical Committee
(Permit Number: 14-220-10 and 14-220-05). Breeding and
experimental work with tsetse flies was approved by the Scientific
Institute Public Health Department Biosafety and Biotechnology
(SBB 219.2007/1410). To minimize mouse suffering and distress
during blood sampling, all animals were anesthetized with
isoflurane using a UNO—Univentor Anesthesia Unit according
to the manufacturer‘s protocol. Mice were monitored daily.
Humane endpoints were used during the study, based on weight
loss, animals with >25% weight loss were sacrificed using carbon
dioxide treatment.
Parasites, Mice, and Infection
Eight to 12 weeks-old male and female wild type C57BL/6 (WT)
mice were purchased from Janvier, France. IL-10−/− (B6.129P2-
Il10tm1Cgn/J), Prdm1eYFP/+ (B6.Cg-Tg(Prdm1-EYFP)1Mnz/J),
Vert-X (B6(Cg)-Il10tm1.1Karp/J), and B cell−/− (B6.129S2-
Ighmtm1Cgn/J) mice were purchased from Jackson Laboratory,
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FIGURE 1 | Uncontrolled inflammation in T. brucei-infected IL-10-deficient mice. (A–C) Cytokine levels were measured by ELISA in plasma of naive mice, infected WT
mice on days 5, 6, 7, 8, and 10 p.i. and naive vs. infected IL-10-deficient mice on day 7 p.i.. Data are represented as mean of 6 mice per group ± SEM and are
representative of 2 independent experiments. (D) Survival of WT and IL-10-deficient mice following T. brucei infection i.p., where the median survival (MS) of each
group is indicated in days. Data are presented as a pool of two representative independent experiments with a minimum of three mice per group, where ***p ≤ 0.001.
USA. CD4Cre/+ Prdm1fl/fl and littermate control Prdm1fl/fl were
kindly provided by A. Scheffold at Charité - Universitätsmedizin
Berlin, Berlin, Germany. CD4Cre/+ IL-10fl/fl and littermate
control IL-10fl/fl mice were initially established in Cardiff
University, Cardiff, United Kingdom (32). All mice were
bred and maintained in the animal facility at the Vrije
Universiteit Brussel.
Pleomorphic T. brucei AnTat 1.1E parasites were obtained
from the Institute for Tropical Medicine, Belgium and stored at
−80◦C as blood aliquots containing 50% Alsever buffer (Sigma-
Aldrich) and 10% glycerol (final V/V). Mice were infected with
5000 clonal AnTat1.1E trypanosomes via intraperitoneal (i.p.)
injection in a volume of 200 µL PBS. Tsetse flies were infected
at the Institute of Tropical Medicine with T. brucei AnTAR1
parasites and selected for mature salivary gland infections as
described previously (33). For each mouse, one individual
infected tsetse fly was used to initiate a natural infection by a
fly bite.
Serum and Cell Isolation
Blood from non-infected control and infected mice at different
time points of infection was harvested via tail-cut using
heparinized capillaries and centrifuged at 8,000 g for 15min.
Serum was harvested and stored at−20◦C.
Leukocyte liver cells were purified by perfusing the liver
with 10ml of cold PBS via the inferior vena cava, mechanical
disruption of the liver, followed by passing cell suspensions over
a 70µm nylon mesh filter. The cells were washed twice with
PBS and centrifuged at 582 g for 7min at 4◦C. After discarding
the supernatant, the pellet was resuspended in a 33% Percoll
solution and centrifuged at 394 g for 7min at room temperature.
After discarding the supernatant, the pellet was resuspended
using ACK lysis buffer (0.15M NH4Cl, 1.0mM KHCO3, 0.1mM
Na2-EDTA) to lyse red blood cells (RBCs) and centrifuged at
394 g for 7min at 4◦C. The pellet was resuspended in complete
medium buffer [RPMI supplemented with 10% FCS, 2mM L-
glutamine, 100 U/ml penicillin and 100µg/ml streptomycin (all
from Invitrogen Life Technologies)]. Spleen and lymph node
cells were isolated as follows. The organs were mechanically
disrupted and RBCs were lysed using ACK lysis buffer (0.15M
NH4Cl, 1.0mM KHCO3, 0.1mM Na2-EDTA). After washing
twice with RPMI at 394 g for 7min at 4◦C, the cell suspensions
were resuspended in complete medium and passed through a
70µm nylon mesh filter.
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Spleen, liver and lymph node cell populations from non-
infected control and infected mice at different time points of
infection were counted and cultured in vitro for cytokine ELISA
or directly analyzed by flow cytometry.
Flow Cytometry
Cells were centrifuged at 394 g for 7min and resuspended
in FACS medium (5% FCS in PBS) at a concentration of
2.106 cells/ml. Non-specific binding sites were blocked by
incubating 20min. at 4◦C with an Fc-blocking antibody (anti-
CD16/32, clone 2.4G2). Next, cell suspensions were stained with
fluorescent conjugated antibodies for 30min at 4◦C. Fluorescent
antibodies: CD11a Pe-Cy7 clone 2D7, CD11b PE-Cy7 clone
M1/70, Ly6C APC clone AL-21, CD4 BV421 clone GK1.5,
CD8 BV510 clone 53–67, NK11 PE clone PK136, TCRß APC
clone H57-597, CD90.2 APC-Cy7 clone Thy1.2, CD138 APC
clone 281-2 (BD Biosciences), B220 BV510 clone RA3-6B2,
CD93 BV421 clone AA4.1, CD1d PE clone 1B1 and CD49d
PE clone 9C10 (eBioscience). Following washing with FACS
buffer the cell suspensions were analyzed on a FACS Canto
II flow cytometer (BD Biosciences) and data was processed
using FlowJo software (Tree Star Inc., Ashland, OR). The
total number of live 7-AAD- cells in each population was
determined by multiplying the percentages of subsets within a
series of marker negative or positive gates by the total live cell
number determined bymicroscopy counting with trypan blue for
each tissue.
Intracellular Cytokine Staining
Spleen and liver cells were incubated in complete medium
at 37◦C for 4 h in the presence of eBioscienceTM Cell
Stimulation Cocktail (plus protein transport inhibitors) (500X)
(ThermoFisher Scientific). Next, cells were washed in PBS at
394 g for 7min at 4◦C, stained for cell surface markers at 4◦C,
washed in PBS at 394 g for 7min at 4◦C and fixed in 1x BD
Cytofix/Cytoperm solution (BD Pharmingen) for 15–20min at
4◦C. They were then washed using a saponin-based buffer (10×
Perm/Wash in FACS buffer; BD Pharmingen) at 394 g for 7min
at 4◦C. After discarding the supernatant, cells were resuspended
and stained with XMG1.2 (anti-IFNγ ; BD Biosciences) in 1x BD
Perm/wash solution for 30min at 4◦C. After washing the cells
with 1x BD Perm/wash solution at 1,400 rpm for 7min at 4◦C,
they were resuspended in PBS and analyzed on a FACS Canto II
flow cytometer (BD Biosciences) and data was processed using
FlowJo software (Tree Star Inc., Ashland, OR). No signal was
detectable with the allophycocyanin-coupled anti-IgG1 isotype
control (eBioscience).
In vitro Cultures
Liver, splenic and lymph node cell populations isolated from
infected and uninfected mice resuspended in complete medium
buffer (cfr previous “Serum and cell isolation” section) were
plated in 48-well plates at 2.106 cells per ml and incubated
at 37◦C in a 5% CO2 incubator for 48 h without any
additional stimulation before supernatant was recovered for
cytokine ELISA.
FIGURE 2 | IL-10 production in mouse spleen and liver cell cultures following
T. brucei infection. Serum and supernatants from ex vivo cultured total spleen
cells, purified leukocyte liver cells from naïve, day 6 and day 8 p.i and pooled
peripheral lymph node (pLN) cells from naïve and day 8 p.i. were analyzed by
ELISA for IL-10 production. Data are represented as mean of at least three
mice per group ± SEM, where *p ≤ 0.05, and are representative of three
independent experiments. The dashed line represents the detection limit.
In vivo Cell Depletion and Neutralization
Experiments
For depletion of CD8+ and CD4+ T cells, mice received the
first i.p. injection of 500 µg anti-CD8 beta and anti-CD4 rat-
anti-mouse monoclonal antibodies (clone YTS169 and GK1.5,
Bioceros in the Netherlands, respectively) 24 h prior to infection.
Subsequently, mice received a dose of 100 µg at 2 days interval
post infection (34). NK and NKT cells were depleted with
the anti-NK1.1 PK136 mouse-anti-mouse monoclonal antibody
(PK136, BioXCell, USA and Bioceros, The Netherlands). Two
hundred and fifty microgram was given 4 and 1 day prior to
infection. A dose of 300 µg was given at 2–3 day intervals
post infection (34). Control mice were treated with a respective
control antibody isotype(all from BioXCell, USA), namely a
monoclonal rat IgG2a isotype as control for the anti-NK1.1
depletion and a monoclonal mouse IgG2b as control for anti-
CD8 and anti-CD4, and the same regimen. Depletion efficiency
of NK and NKT cells as well as CD8+ and CD4+ T cells from
both spleen and liver was assessed by flow cytometry and was
confirmed to be above 90%.
For neutralization of IL-27, wild type mice were treated with
500µg of an anti-IL-27 antibody (MM27.7B1) or a control IgG2a
antibody once a week (32, 35–37).
Quantification of Cytokines
Cytokines were quantified using a V-PLEX Custom Mouse
Cytokine kit (catalog number K152A0H) from Meso
Scale Discovery (Rockville, MD, USA) according to the
manufacturer’s protocol. Alternatively, culture medium and
serum concentrations of IL-6, TNF, IFN-γ, and IL-10 (R&D
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Systems) were determined by ELISA as recommended by
the suppliers.
Bone Marrow Chimera
Eight weeks-old C57BL/6 mice were irradiated at 1000 Rads
using a Cesium source irradiator at IBMM, Gosselies, Belgium.
The next day irradiated mice were transplanted intravenously
with 107 bone marrow cells isolated from femurs and tibias of
either IL-10-deficient mice or wild-type (WT) C57BL/6 mice.
Briefly, bones were harvested and cells were flushed with PBS
using a 27 gauge needle and syringe. Cell clumps were dissociated
via up-and-down pipetting, filtered through a 70µm nylon
mesh filter and washed in PBS at 394 g for 7min at 4◦C.
Red blood cells were lyzed using RBC lysis buffer, washed in
PBS at 394 g for 7min at 4◦C and counted. Animals were
kept under Sulfatrim antibiotic [sulfamethoxazole/trimethoprim,
to be added to the drinking water (5/200ml)] for 4 weeks
post-irradiation.
Statistics
The GraphPad Prism 7 software was used for statistical analyses
(student t-test for paired analyses and Log-rank (Mantel-Cox)
test for survival). Values are expressed as mean ± SEM, where
∗p ≤ 0.05, ∗∗p ≤ 0.01, ∗∗∗p ≤ 0.001, and ∗∗∗∗p ≤ 0.0001.
RESULTS
Clearance of Parasitemia in T.
brucei-Infected Mice Is Followed by the
Production of IL-10 in Spleen and Liver
In Antat1.1E T. brucei-infected wild-type (WT) C57BL/6 mice,
peak parasitemia is reached around day 6 post-infection
(p.i.) (Supplementary Figure 1) and blood parasitemia control
correlates with the development of a pro-inflammatory response
characterized by increased levels of TNF, IFNγ, and IL-6,
which peaks around day 7 and then decreases toward 10
p.i. (Figures 1A–C). Early after infection, IL-10 production is
absolutely necessary to dampen the pathogenic effects of these
pro-inflammatory cytokines, as mice deficient in IL-10 (IL-
10 KO mice) exhibit increased levels of the pro-inflammatory
cytokines IFNγ and TNF (Figures 1A–C), and die around 8–9
days p.i. (Figure 1D). Interestingly, the increased inflammation
observed in IL-10 KO mice has no effect on parasitemia levels
(6, 29).
Given the essential role for IL-10 in controlling T. brucei
pathogenesis, serum IL-10 levels and IL-10 secretion in ex vivo
splenic, liver and pooled peripheral lymph node (axillary and
inguinal) cell cultures were measured. IL-10 protein in the serum
of T. brucei infected WT mice peaks around day 8 p.i., which
corresponds to the time at which IL-10 KOmice start to succumb
to the infection (Figure 2). In spleen and liver cell cultures, local
production of IL-10 is detected at day 6 and 8 post-infection
without the addition of ex vivo stimuli (Figure 2). This contrasts
with the nearly complete absence of IL-10 secretion measured
in pooled peripheral lymph nodes at the same time points
(Figure 2). Together, these results suggest that IL-10 produced
FIGURE 3 | Hematopoietic cells constitute a major source of IL-10 production
during T. brucei infection. (A) Survival of the chimeric mice 8 weeks
post-transplantation as well as IL-10-deficient mice following T. brucei
infection i.p., where the median survival (MS) of each group is indicated in
days. (B) Cytokine levels were measured by ELISA in plasma of infected
chimeric and IL-10-deficient mice 8 days p.i.. Data are represented as mean of
at least 4 mice per group ± SEM, where *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001,
and are representative of 2 independent experiments. The dashed line
represents the detection limit.
in liver and spleen is crucial in dampening pro-inflammatory
cytokines induced during parasitemia.
Identification of IL-10 Producing Cells
During Early T. brucei Infection
Numerous cell types, particularly hematopoietic cells, have the
potential to produce IL-10. Hence, in order to understand the
role of IL-10 in trypanosomosis, the main cellular origin needs
to be known. IrradiatedWTmice repopulated with bone marrow
cells from IL-10 KO mice exhibit comparable susceptibility to T.
brucei-induced death as compared to full IL-10 KO mice, while a
transfer withWT-derived cells completely rescued the phenotype
(Figure 3A). The analysis of cytokine levels present in serum at
day 8 p.i. in these mice reveals that recipients of IL-10 KO bone
marrow display significantly higher IFNγ (3,374± 66 pg/ml) and
TNF (2,101 ± 83 pg/ml) as compared to WT mice that received
WT bone marrow cells (Figure 3B). Coincidingly, a dramatic
reduction in infection-associated IL-10 (105 ± 18 pg/ml) is
observed (Figure 3B), phenocopying the results observed in IL-
10 KO mice. Importantly, the small amount of IL-10 still present
in irradiated WT mice receiving IL-10 KO bone marrow cells
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FIGURE 4 | Cellular characterization of IL-10 producing cells in spleen and liver following T. brucei infection. (A) Percentages and (B) total cell number of IL-10
producing cells in infected liver (LI inf) and spleen (SP inf) at day 3, 6, and 8 p.i.. (C) Relative contribution of the different cellular sources producing IL-10. The surface
of the diagram is representative of the total number of IL-10+ cells present in liver and spleen at day 6 and day 8 p.i., which is described in (B). (D) Histogram showing
the intensity of IL-10-eGFP signal as well as the percentage and MFI of IL-10+ cells in different cell subsets. The red dotted line is giving an indication of the relative
IL-10-eGFP signal differences between the different cell subsets, whereas the gray histogram represent the relative IL-10-eGFP signal of these different cell subsets in
infected non-reporter mice. Data are represented as mean of at least three mice per group ± SEM, where *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, and are representative
of 3 independent experiments.
is insufficient to reduce the overall pro-inflammatory cytokine
production in these mice.
As IL-10 derived from the hematopoietic compartment is
mandatory to counteract the excessive production of pro-
inflammatory cytokines during early T. brucei infection and
prevent early death, the radiosensitive source(s) of IL-10 was
investigated using VERT-X IL-10eGFP reporter mice, encoding
enhanced GFP (eGFP) in the 3’ UTR of the Il10 gene (31). The
specificity of the IL-10eGFP signal was tested in both liver and
spleen, as infected non-reporter WT mice did not show any
increase in eGFP signal compared to Vert-X IL-10eGFP reporter
mice (Supplementary Figure 2). First, we follow the evolution of
the IL-10eGFP signal expressed in percentage and total numbers
within both the liver and spleen during the first 8 days p.i.
(Figures 4A,B). In the liver a slight increase in the percentage
of IL-10eGFP+ cells was observed toward day 3 p.i., peaking at
day 6 p.i. and declining slightly around day 8 p.i. In the spleen,
the percentage of IL-10eGFP+ cells only increase considerably
at day 8 p.i. (Figure 4A). In absolute numbers of IL-10eGFP+
cells, there is a similar increase in both liver (4.8 106 ± 0.2)
and spleen (5.9 106 ± 0.3) at day 6 p.i. compared to day 3
p.i. In the case of the spleen, but not the liver, we observed
a substantial further increase in IL-10eGFP+ cell numbers by
day 8 after infection (Figure 4B). These results mirror the IL-10
production data recorded in the corresponding ex vivo cultures
of these organs (Figure 2).
Investigating the cellular source of the IL-10eGFP signal at
day 6 and day 8 p.i. in both liver and spleen shows that NK
cells (NK1.1+ TcRαβ−) and CD8+ T (CD8α+ TcRαβ+) cells
are the main source of IL-10 at day 6 p.i. (30.7% ± 0.3%
and 35.2% ± 9.1% of all eGFP+ cells, respectively), as well as
at day 8 p.i. (22.4% ± 2.3% and 37.0% ± 1.8%, respectively)
in livers of infected mice (Figure 4C). Interestingly, NK cells
(NK1.1+ TcRαβ−) and CD8+ T (CD8α+ TcRαβ+) cells were
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also both recently identified as the main producers of IFNγ in
response to T. brucei infection (34), In the spleen, the main
IL-10eGFP+ cell populations are non-plasma B cells (B220hi
CD138−) at day 6 p.i. (36.9% ± 4.7%), whereas IL-10+ plasma
cells (B220int CD138+) predominant (52.9% ± 4.5%) at day 8
p.i. with nearly all plasma B cells showing positive IL-10eGFP
expression at the later timepoint (Figure 4D). Importantly,
CD4+ T cells show a double expression profile, with the IL-
10 positive population expressing a 3- to-4-fold increased mean
fluorescence intensity (MFI) compared to the other subsets (red
dashed line) (Figure 4D), suggesting a higher IL-10 expression by
this cell subset.
These data reveal that different cell types, such as NK cells,
CD8+ T cells, and CD4+ T cells, and B cells, have the potential to
produce IL-10 during early experimental trypanosomosis.
Natural Tsetse Fly-Mediated T. brucei
Infection Induces the Same IL-10
Producing Cells as the Intraperitoneal
Infection
In most experimental trypanosomosis studies, mice are infected
by intraperitoneal (i.p.) injections of parasites. To evaluate the
relevance of our results under a more biologically relevant
condition, the survival of IL-10-deficient mice following T.
brucei-infected tsetse fly-mediated infection was monitored.
IL-10 KO mice infected via the natural route all succumb
within 10 days p.i., similar to intraperitoneally infected IL-
10 KO mice (Figure 5A). In agreement with the results
obtained following i.p. infection (Figure 1), tsetse fly-mediated
infection induces a significant increase in IFNγ and TNF
levels, which is further aggravated in IL-10 KO mice, at day 6
p.i. (Figure 5B).
Following the natural route of a T. brucei infection, the
liver exhibits the highest frequency of IL-10eGFP+ cells, as
compared to the spleen, both at day 4 and day 7 p.i.
(Figure 6A). However, due to the occurrence of splenomegaly,
the spleen contains a higher actual number of IL-10eGFP+
cells at day 7 p.i. as compared to the liver (12.6 106
± 2.5 vs. 3.8 106 ± 0.6, respectively) (Figure 6B), which
mirrors the results obtained following i.p. infection. Also
here, NK cells, CD8+ T cells, CD4+ T cells subsequently
followed by non-plasma and plasma B cells remain the most
abundant cell types producing IL-10 at day 7 p.i., the time
point when IL-10 KO mice infected via the natural route
start to succumb from the pro-inflammatory cytokine storm
(Figure 6C).
Relative Importance of the IL-10-Producing
Cell Subsets Following T. brucei Infection
As shown by the data compiled above, NK and T cells constitute
a potential early source of IL-10 during T. brucei infection
(Figure 4). Therefore, these cells were pharmacologically
depleted and subsequently the levels of IL-10 in the circulation
at day 6 and day 9 post-infection were measured (Figure 7A).
The results confirm the contribution of NK and T cells on
systemic IL-10 levels at both day 6 (184 ± 34 pg/ml vs. 76 ± 7
FIGURE 5 | Survival and inflammation profile of IL-10-deficient mice
inoculated with T. brucei infected tsetse fly. (A) Survival of WT and
IL-10-deficient mice after T. brucei infection via tsetse fly, where the median
survival (MS) of each group is indicated in days. Data are represented as mean
of at least 6 mice per group ± SEM and are representative of 2 independent
experiments. (B) Cytokine levels were measured by ELISA in plasma of
infected WT and IL-10-deficient mice at 6 days p.i.. Data are represented as
mean of at least four mice per group ± SEM, where *p ≤ 0.05, ***p ≤ 0.001,
and are representative of three independent experiments. The dashed line
represents the detection limit.
pg/ml) and day 9 (502 ± 68 pg/ml vs. 152 ± 15 pg/ml) post-
infection. As we confirmed that the peak of IL-10 in the serum
occurs post peak parasitemia, round day 8–9 post infection,
the role of these individual cell subsets, i.e., NK cells as well
as CD8 and CD4T cells, on the circulating levels of IL-10 was
evaluated at day 9 post-infection (new Figure 7B). The results
demonstrate that both CD8+ and CD4+ T cells, in contrast to
NK cells, play a role in the systemic production of IL-10 at day
9 post-infection.
Taken the importance of both T cell subsets and the
very high level of IL-10eGFP expression in the cytokine
positive CD4+ T cell population, the role of these cells
was assessed in more detail using T. brucei infected mice,
which are pharmacologically depleted in both CD8+ and
CD4+ T cells. In these mice, serum IL-10 levels at day
9 p.i.were 70–75% lower compared to WT mice (234 ±
48 pg/ml vs. 66 ± 16 pg/ml) (Figure 7C). Together, these
results confirm that T cells constitute an important source of
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FIGURE 6 | Cellular characterization of IL-10 producing cells in spleen and liver following T. brucei infection by tsetse fly. (A) Percentages and (B) total cell number of
IL-10 producing cells in infected liver (LI inf) and spleen (SP inf) at day 4 and 7 p.i. (C) Relative contribution of the different cellular sources producing IL-10. The
surface of the diagram is representative of the total number of IL-10+ cells present in liver and spleen at day 4 and day 7 p.i., which is described in (B). Data are
represented as mean of at least three mice per group ± SEM, where ***p ≤ 0.001, and are representative of three independent experiments.
systemic IL-10 as well as the data obtained at day 9 p.i. in
Figure 7A.
To further characterize these IL-10-producing T cells,
they were assessed for their levels of CD11a and CD49d
expression. These are typical markers for activated and antigen-
experienced effector type 1 regulatory T (Tr1) cells that are
known for their combined capacity to produce both IFNγ
and IL-10 (38–40). Figure 7D shows that ∼18 and 38% of
the antigen-experienced CD11a+ CD49d+ CD8+ and CD4+
T cells (red), respectively, are IL-10eGFP+, whereas <1 and
6% of the non-antigen experienced CD8+ and CD4+ T cells
(blue) are IL-10eGFP+ at day 8 p.i. (Figure 7D). Moreover,
within the IL-10eGFP+ T cell populations, 50% of the CD8+
T cells and 45% of the CD4+ T cells co-express IFNγ ,
implying the presence of Tr1 cells in T. brucei-infected
WT mice.
IL-10 Production Following T. brucei
Infection Occurs Independently of IL-27
To gain further insight into the mechanism of IL-10 upregulation
following T. brucei infection the role of IL-27 was assessed.
This member of the IL-12 cytokine family has been shown
to promote IL-10 production by various T cell subsets via
IL-27 receptor engagement and subsequent STAT3-dependent
signaling (19, 41, 42). However, blocking IL-27, using an anti-
IL-27 neutralizing antibody, in T. brucei-infected Vert-X mice
did not alter frequencies of splenic IL-10eGFP+ cells, nor did
it change the IL-10 levels in ex vivo cultured spleen cells or
in serum at day 9 p.i. (Figures 8A,B). Hence measurement
of systemic IL-10 production either before (day 6) or after
(day 12) the day 9 peak shows a gradual increase of IL-10
during the course of the anti-IL-27 treatment and T. brucei
infection (Figure 8C), which is in line with previous results (43).
Also, similar to published data obtained in the T. congolense
model using IL-27R-deficient mice (43), blocking of IL-27 during
T. brucei infection results in an increased pro-inflammatory
cytokine storm characterized by increased serum levels of IFNγ
(886 ± 52 pg/ml vs. 156 ± 17 pg/ml) and TNF (353 ±
18 pg/ml vs. 202 ± 5 pg/ml), which is associated with a
shortened survival (15 days vs. 55 days in control antibody-
treated mice) (Supplementary Figures 3A,B). Together, these
data does confirm the importance of IL-27 with respect to
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FIGURE 7 | Cellular source of IL-10 production following T. brucei infection. IL-10 levels were measured by ELISA in plasma of infected WT and anti-NK-, anti-CD8-
and CD4-treated WT at day 6 and 9 p.i. (A) as well as in WT and anti-CD8- or CD4-treated or anti-NK1.1-treated WT mice (B) and in WT and anti-CD8- and
CD4-treated 9 days p.i. (C). (D) At day 8 p.i., CD11a and CD49d expression on splenic CD8+ and CD4+ T cells was analyzed. Both CD11a+ CD49d+ and CD11a−
CD49d− CD8+ and CD4+ T cell subsets were analyzed for the expression of IL-10eGFP and intracellular expression of IFNg. Data are represented as mean of at least
four mice per group ± SEM, where *p ≤ 0.05, **p ≤ 0.01, and are representative of two independent experiments.
its anti-inflammatory role during T. brucei infection. However,
in contrast to the expectation, the data show that IL-27 does
not provide a co-stimulatory signal for the actual infection-
associated IL-10 production by T cells or the induction of IL-
10eGFP+ cells.
Blimp-1 Expression in T Cells Is Required
to Regulate Inflammation Following T.
brucei Infection
Recently, numerous reports have demonstrated a role for
the transcriptional regulator B lymphocyte-induced maturation
protein-1 (Blimp-1), encoded by the Prdm1 gene, in T
cell homeostasis and function, but also in the control of
systemic inflammation predominantly via the regulation of IL-
10 production (17, 18, 44, 45). However, Blimp-1 has also been
described to directly dampen T cell and NK cell activation
and proliferation as well as the production of pro-inflammatory
cytokines such TNF and IFNγ (45–47). In addition, plasma
cells are known to express high levels of Blimp-1, as this
factor is mandatory for the differentiation of B cells into
antibody secreting cells (48, 49). Using Blimp-1eYFP reporter
mice (Blimp-1eYFP/+), we found that the major cellular sources
of Blimp-1 are similar to those producing IL-10eGFP during the
first 9 days of infection, namely NK cells and T cells in the liver at
day 6 p.i. as well as mainly T cells in the liver and plasma B cells
in the spleen, at day 9 p.i (Supplementary Figure 4).
To evaluate a possible correlation between IL-10 production
and the expression of the Prdm1 gene in T cells, the production
of IL-10 by both CD8+ and CD4+ T cells was analyzed
in mice with a conditional deletion of Prdm1 within the T
cell lineage (CD4Cre/+ Prdm1fl/fl, Prdm1 CKO) and littermate
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FIGURE 8 | IL-27-independent IL-10 production following T. brucei infection. (A) Splenic percentage of IL-10eGFP+ as well as (B) IL-10 levels in supernatant of ex
vivo spleen cell cultures and in serum were assessed in untreated and anti-IL-27-treated infected Vert-X mice. IL-10 levels were measured by ELISA in plasma of
infected WT and anti-IL-27-treated WT at day 6, 9, and 12 p.i. (C). Data are represented as mean of minimum 4 mice per group ± SEM, where ***p ≤ 0.001, and are
representative of at least TWO independent experiments.
CD4+/+ Prdm1fl/fl controls (Prdm1 WT) following T. brucei
infection. Interestingly, the loss of Prdm1 expression in T cells
leads to an almost complete absence of IL-10 production by
splenic CD8+ and CD4+ T cell subsets compared to WT
mice at day 9 p.i. (Figure 9A). As mentioned previously,
Prmd1 is also implicated in dampening T cell activation and
pro-inflammatory cytokine production. This is confirmed by
the finding that during T. brucei infection of Prdm1 CKO
mice, an increased frequency of activated antigen-experienced
splenic CD8+ and CD4+ T cells is observed by day 12
p.i. (based on CD11a and CD49d expression) (Figure 9B).
Consequently, these mice also display increased serum level
of pro-inflammatory cytokines, e.g., IFNγ (205 ± 26 pg/ml
vs. 79 ± 19 pg/ml) and TNF (3518 ± 625 pg/ml vs. 1,040
± 188 pg/ml), at day 12 p.i. (Figure 9C). This sustained
systemic increase in pro-inflammatory cytokines is associated
with a premature death of infected conditional KO mice
(Figure 9D).
DISCUSSION
The crucial role of IL-10 in dampening pro-inflammatory
responses in order to avoid immunopathology is well-established
(4, 50). In the case of T. brucei infection, IL-10 is necessary
to down-modulate the inflammatory response and to prevent
death of the host from a hyper-inflammation syndrome. Indeed,
IL-10 KO mice started to succumb on day 8 p.i. due to the
uncontrolled presence of high pro-inflammatory cytokine levels,
such as IFNγ and TNF. In contrast, the IL-6 cytokine does
not seem to play a major role in this phenomenon as we did
not detect any significant difference in IL-6 levels between IL-
10 KO and WT mice in nearly all experimental settings. In
some infectious settings, the absence of IL-10 can be associated
to the development of immunopathology mediated by the pro-
inflammatory IL-17 cytokine, which is mainly driven by the
IL-6 production. For example, the absence of IL-10 leads to
IL-17-mediated immunopathology during infection with the
intracellular Leishmania major parasite (51). However, our
unpublished observation shows that the lack of IL-10 does not
induce any systemic IL-17 levels above detection limit, which
correlates with similar IL-6 levels observed between IL-10 KO
and WT mice during T. brucei infection.
Until now, the cell types responsible for IL-10 secretion in
the T. brucei trypanosome infection model have never been
well-characterized. Since many immune hematopoietic-derived
cells have the capacity to produce IL-10 (8–10, 14, 52), we first
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FIGURE 9 | T cell-derived Blimp-1 signaling pathway is required to dampen inflammation following T. brucei infection. (A) Percentage of splenic IL-10+ CD8+ and
CD4+ T cell subsets was analyzed at day 9 p.i. both in WT and T cell-specific Prdm1-deficient (Prdm1 CKO) mice following T. brucei infection. (B) The CD11a and
CD49d expression on splenic CD8+ and CD4+ T cells were analyzed at day 12 p.i. in WT and T cell-specific Prdm1-deficient (Prdm1 CKO) mice. Data are represented
as mean of at least 3 mice per group ± SEM and are representative of 3 independent experiments. (C) Cytokine levels in serum at day 12 p.i. and (D) survival of WT
and Prdm1 CKO mice were monitored following T. brucei infection, where the median survival (MS) of each group is indicated in days. Data are represented as mean
of at least four mice per group ± SEM, where *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001, and are representative of two independent experiments.
confirmed that the radiosensitive bone marrow compartment is
the main source of this cytokine. Also, day 8 p.i. coincides with
the highest level of IL-10 in the serum and ex vivo liver and
spleen cell cultures, whereas no IL-10 could be detected in cell
cultures from peripheral andmesenteric lymph nodes. Moreover,
the data obtained on IL-10 production from ex vivo cell cultures
correlates with the total number of IL-10eGFP+ cells in liver and
spleen at day 6 and 8 p.i. using the Vert-X mice. For example, no
difference in the IL-10 level and IL-10eGFP+ cell number were
observed at day 6 p.i. in liver and spleen as well as day 8 p.i.
in liver.
In order to characterize the different immune cell types
producing IL-10 in these tissues at different time points
after infection, Vert-X IL-10eGFP reporter mice were used.
The study identified NK, T and B cells as producers of
IL-10 during the acute phase of T. brucei infection. For
example, in the liver, the main sources of IL-10 are NK
and CD8+ T cells, both at early and later time points.
The early production of IL-10 by NK cells also plays a
crucial role during the infection with rapidly disseminating
parasites, e.g., Toxoplasma gondii, Listeria monocytogenes, and
Yersinia pestis (8) as well as during the late stage of murine
visceral leishmaniasis (53), by counteracting the production
of inflammatory cytokines such as IL-12. Another study also
reported the anti-inflammatory IL-10 property of antiviral
effector CD8+ T cells in the lung during acute influenza
virus infection (13). In the spleen, non-plasma and plasma B
cells predominate as a source of IL-10 at day 6 and 8 p.i.,
respectively. Recently, many B cell types, such as T2-MZP
cells (CD19+CD21hiCD23hiCD1dhi), B10 cells (CD5+CD1dhi),
and MZB cells (CD23−CD21hiCD1dhi), were shown to possess
intrinsic regulatory properties mainly via the production of IL-
10 (54–56). Madan et al. already described that CD19+ B cells
represent a dominant population of IL-10-expressing cells in the
spleen after diverse in vivo stimuli, such as lipopolysaccharide,
CpG, goat anti-IgD and mouse cytomegalovirus infection
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(31). IL-10-producing plasmablasts can also exert a regulatory
function in autoimmune inflammation (57). However, the
protective role of B cell-derived IL-10 was negligible in our
experimental model, at least during the acute phase of infection,
as the genetic deletion of B cells does not significantly impact
the levels of IL-10 in the serum at day 8 p.i., a time point
when IL-10 KO mice starts to succumb from an uncontrolled
inflammatory response.
Our results also demonstrated that IL-10 KO mice
infected with T. brucei via the natural route, using tsetse
flies, succumbed with a similar kinetic from an uncontrolled
pro-inflammatory cytokine storm, mainly consisting of IFNγ
and TNF. In addition, the different IL-10-producing cell
types in this model are comparable to the ones following
i.p. administration of T. brucei. Together, these results fit
with the hypothesis that systemically disseminating parasites
induce a chronological cell programming, leading to IL-
10 production in order to counterbalance the production
of pro-inflammatory cytokines and to avoid premature
host death.
Cellular and Molecular Regulation of IL-10
Production
The resistance to T. brucei infection relies on the development
of a typical Type 1 immune response characterized by the
production of pro-inflammatory cytokines such as IFNγ and
TNF (24, 58). However, this inflammatory response, which is
mainly driven by effector T cells, must be tightly regulated
in order to avoid immunopathology and potentially an early
death. Our study demonstrates that NK and T cells constitute
sequential sources of IL-10. These are the exact same cell types
that have recently been shown to produce IFNγ following T.
brucei infection (34). Effector NK and T cells possess the capacity
to produce both inflammatory and anti-inflammatory cytokines
in various pathogenic models. For example, Tr1 cells can produce
IL-10 and IFNγ at the same time (10, 18, 20, 59). In our
murine model, we have shown that antigen-experienced IFNγ+
CD11a+ CD49d+ T cells are the main producers of IL-10,
suggesting that this activated CD4+ T cell subset corresponds
to Tr1 cells. The genetic and pharmacological depletion of T
cells drastically reduced the levels of IL-10 in the serum of T.
brucei-infected mice.
As IL-27 is known to play an important role in the
regulation of IFNγ during trypanosome infection as well as to
modulate IL-10 production in other models (19, 32, 41, 42),
we investigated whether IL-27 was affecting IL-10 levels during
T brucei infection. As previously shown by the group of Shi
in the T. congolense model (43), we did not find any clear
role for IL-27 in IL-10 production during the early stages of
T. brucei infection. For example, within the first 12 days p.i.
during African trypanosomosis, the levels of IL-10 in serum
and ex vivo spleen culture supernatant from infected anti-IL-
27-treated mice were similar, or even higher at day 12 p.i.,
to the ones monitored in untreated WT mice. In addition,
the percentage of IL-10+ cells is also similar between both
groups. Therefore, the exact immunoregulatory role of IL-27
in the context of African trypanosomosis remains ambiguous.
However, different studies focusing on the anti-inflammatory
role of IL-27 in the context of parasitic infections, such as
malaria, Trypanosoma cruzi and African Trypanosomosis, but
also in viral infection, assign an important role of IL-27 in the
regulation of CD4+ T cell activation and recruitment, to avoid
IFNγ -mediated immunopathology (43, 60–63). For example,
during cytomegalovirus infection, IL-27 signaling restricts the
development of virus-specific CD4+ T cells displaying a cytotoxic
phenotype via the inhibition of the transcription factor T-bet
expression (63).
Overall, these data suggest that T cells play an important role
in the generation of an early IL-10-mediated anti-inflammatory
response, which occurs independently of IL-27.
Prdm1, the gene coding for Blimp-1, is a master regulator
of plasma cell differentiation (49, 64) and, more recently,
the expression of Blimp-1 in CD8+ and CD4+ T cells has
been demonstrated to regulate homeostasis and activation
via induction of IL-10 and dampening of IL-2 and IFNγ
expression (17, 45). Using Blimp-1eYFP reporter mice, we
demonstrated that Blimp-1-expressing cells largely overlap with
IL-10 expressing cells, namely NK cells and T cells in liver
and plasma B cells in spleen. Importantly, T brucei-infected
mice harboring a conditional deletion of Prdm1 in T cells
succumbed from uncontrolled inflammation within 2 weeks p.i..
Numerous recent publications have identified Blimp-1 as a major
regulator of T cell activation, mainly by controlling IL-10 and
pro-inflammatory cytokine production by both CD8+ and Tr1
CD4+ T cells (18, 20, 44, 46, 47). In our T. brucei infectionmodel,
we demonstrated a similar role for Prdm1 in positively regulating
IL-10 expression in T cells as well as dampening their activation
and subsequent pro-inflammatory status.
Together, these results suggest that the production of IL-10
during acute T. brucei infection constitutes a tightly regulated
process both at the cellular and molecular level. Our data
demonstrates that the production of IL-10 by CD8+ and
CD4+ T cells is required to dampen the production of pro-
inflammatory cytokines by these same cell types early after
infection. This study also highlights the importance of the
Prdm1 transcription factor within the T cell compartment, which
controls their IL-10 production, their activation status as well as
the production of inflammatory cytokines. In conclusion, Prdm1
acts independently of IL-27 as a master regulator of inflammation
during T. brucei infection.
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